Companies / Galectin Therapeutics Inc

Galectin Therapeutics Inc

Nasdaq: GALTCIK 1133416NORCROSS, GA
Insider flow · last 90 daysNet sells $438.5K

Financials

Revenue
Net income$-30.84M
Total debt
Cash$14.11M
Diluted EPS$-0.48
Shares outstanding65.9M

Ownership

65.9M shares outstanding · as of May 8, 2026
17.1%Insiders
Ownership
Insiders17.08%11,245,064
Institutions24.10%15,874,202
Public float58.82%38,737,632

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 13

View all →
Insider% of sharesShares
Uihlein Richard EDirector · 10% owner
15.69%10,332,676
Lewis JoelCEOPresident and CEO · Director
1.26%832,592
Eldred KaryDirector
0.10%65,682
Callicutt Jack WChief Financial Officer
0.01%7,614
<0.01%6,500
Jamil KhurramChief Medical Officer
0.00%0
Brem HenryFormerDirector

Institutional holders 101

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 29, 2026Jamil Khurram
Executive
SellCommon Stock$239.2K-47K
-100.00%
0
0.00% of shares
medium
Jan 6, 2026Lewis Joel
CEO
SellCommon Stock$134.9K-38K
-4.33%
832,592
1.26% of shares
medium
Jun 29, 2026Jamil Khurram
Executive
ExerciseCommon Stock$118.7K+47K
47,467
0.07% of shares
low
Jun 29, 2026Shlevin Harold H.
Director
SellCommon Stock$112.2K-22K
-77.41%
6,500
<0.01% of shares
medium
Jan 5, 2026Lewis Joel
CEO
SellCommon Stock$108.3K-28K
-3.09%
870,290
1.32% of shares
medium
Jan 5, 2026Callicutt Jack W
Executive
SellCommon Stock$100.3K-26K
-47.92%
27,968
0.04% of shares
medium
Jan 5, 2026Jamil Khurram
Executive
SellCommon stock$99.4K-25K
-54.32%
21,446
0.03% of shares
low
Jan 6, 2026Jamil Khurram
Executive
SellCommon Stock$78.2K-21K
-100.00%
0
0.00% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
GALTCommon StockEquity363225202BBG000BK6FP5